• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

区域化作为加强监管体系的一种方法:以加勒比共同体成员国为例的研究。

Regionalization as an approach to regulatory systems strengthening: a case study in CARICOM member states.

作者信息

Preston Charles, Chahal Harinder S, Porrás Analia, Cargill Lucette, Hinds Maryam, Olowokure Babatunde, Cummings Rudolph, Hospedales James

出版信息

Rev Panam Salud Publica. 2016 May;39(5):262-268.

PMID:27706404
Abstract

Improving basic capacities for regulation of medicines and health technologies through regulatory systems strengthening is particularly challenging in resource-constrained settings. "Regionalization"-an approach in which countries with common histories, cultural values, languages, and economic conditions work together to establish more efficient systems-may be one answer. This report describes the Caribbean Regulatory System (CRS), a regionalization initiative being implemented in the mostly small countries of the Caribbean Community and Common Market (CARICOM). This initiative is an innovative effort to strengthen regulatory systems in the Caribbean, where capacity is limited compared to other subregions of the Americas. The initiative's concept and design includes a number of features and steps intended to enhance sustainability in resource-constrained contexts. The latter include 1) leveraging existing platforms for centralized cooperation, governance, and infrastructure; 2) strengthening regulatory capacities with the largest potential public health impact; 3) incorporating policies that promote reliance on reference authorities; 4) changing the system to encourage industry to market their products in CARICOM (e.g., using a centralized portal of entry to reduce regulatory burdens); and 5) building human resource capacity. If implemented properly, the CRS will be self-sustaining through user fees. The experience and lessons learned thus far in implementing this initiative, described in this report, can serve as a case study for the development of similar regulatory strengthening initiatives in resource-constrained environments.

摘要

在资源有限的环境中,通过加强监管系统来提高药品和卫生技术监管的基本能力尤其具有挑战性。“区域化”——一种让具有共同历史、文化价值观、语言和经济状况的国家共同努力建立更高效系统的方法——可能是一个解决方案。本报告介绍了加勒比监管系统(CRS),这是一项在加勒比共同体和共同市场(加共体)多数小国实施的区域化倡议。该倡议是加强加勒比地区监管系统的一项创新举措,与美洲其他次区域相比,该地区的能力有限。该倡议的概念和设计包括一些旨在提高资源有限环境下可持续性的特点和步骤。后者包括:1)利用现有的集中合作、治理和基础设施平台;2)加强对公共卫生影响最大的监管能力;3)纳入促进依赖参考当局的政策;4)改变系统以鼓励行业在加共体销售其产品(例如,使用集中的进口门户以减轻监管负担);5)建设人力资源能力。如果实施得当,CRS将通过用户收费实现自我维持。本报告中描述的到目前为止在实施该倡议过程中的经验和教训,可作为在资源有限环境中制定类似监管加强倡议的案例研究。

相似文献

1
Regionalization as an approach to regulatory systems strengthening: a case study in CARICOM member states.区域化作为加强监管体系的一种方法:以加勒比共同体成员国为例的研究。
Rev Panam Salud Publica. 2016 May;39(5):262-268.
2
Fifty years of the European medicines regulatory network: reflections for strengthening intra-regional cooperation in the Region of the Americas.欧洲药品监管网络五十年:关于加强美洲区域内区域合作的思考
Rev Panam Salud Publica. 2016 May;39(5):288-293.
3
[Strengthening health regulation in the Americas: regulatory authorities of regional reference].[加强美洲地区的卫生监管:区域参考监管机构]
Rev Panam Salud Publica. 2016 May;39(5):294-298.
4
Sharing regulatory data as tools for strengthening health systems in the Region of the Americas.共享监管数据作为加强美洲区域卫生系统的工具。
Rev Panam Salud Publica. 2016 May;39(5):245-254.
5
[South-South cooperation to strengthen the medicines control laboratories of the Caribbean community (CARICOM)].
Rev Panam Salud Publica. 2016 May;39(5):269-273.
6
Establishing a regulatory value chain model: An innovative approach to strengthening medicines regulatory systems in resource-constrained settings.建立监管价值链模型:一种在资源有限环境中加强药品监管系统的创新方法。
Rev Panam Salud Publica. 2016 May;39(5):299-305.
7
An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017-2018 using the OpERA methodology.使用OpERA方法对2017 - 2018年提交的药品进行加勒比监管系统集中评估过程的评估。
J Pharm Policy Pract. 2020 Sep 8;13:56. doi: 10.1186/s40545-020-00261-z. eCollection 2020.
8
From Port-of-Spain summit to United Nations High Level Meeting CARICOM and the global non-communicable disease agenda.从西班牙港峰会到联合国高级别会议:加勒比共同体与全球非传染性疾病议程
West Indian Med J. 2011 Jul;60(4):387-91.
9
Addressing the challenges of regulatory systems strengthening in small states.解决小国家监管体系强化面临的挑战。
BMJ Glob Health. 2020 Mar 2;5(2):e001912. doi: 10.1136/bmjgh-2019-001912. eCollection 2020.
10
Health policy and regulatory authorities: challenges of technology regulation in Public Health Emergencies.卫生政策和监管机构:突发公共卫生事件中技术监管的挑战。
Cien Saude Colet. 2024 Jul;29(7):e03442024. doi: 10.1590/1413-81232024297.03442024. Epub 2024 Feb 29.

引用本文的文献

1
Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality.评估海湾合作委员会集中监管审查程序的绩效:提高产品授权效率和质量的策略。
Pharmaceut Med. 2022 Aug;36(4):223-231. doi: 10.1007/s40290-022-00432-0. Epub 2022 Jun 29.
2
Pharmaceutical procurement among public sector procurers in CARICOM.加勒比共同体公共部门采购商的药品采购情况。
Rev Panam Salud Publica. 2021 May 20;45:e57. doi: 10.26633/RPSP.2021.57. eCollection 2021.
3
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.
拉丁美洲和加勒比地区国家在批准新药品方面对监管的依赖。
Rev Panam Salud Publica. 2021 Apr 9;45:e10. doi: 10.26633/RPSP.2021.10. eCollection 2021.
4
Making the investment case for national regulatory authorities.为国家监管机构阐述投资理由。
J Pharm Policy Pract. 2021 Jan 21;14(1):16. doi: 10.1186/s40545-021-00299-7.
5
An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017-2018 using the OpERA methodology.使用OpERA方法对2017 - 2018年提交的药品进行加勒比监管系统集中评估过程的评估。
J Pharm Policy Pract. 2020 Sep 8;13:56. doi: 10.1186/s40545-020-00261-z. eCollection 2020.
6
Addressing the challenges of regulatory systems strengthening in small states.解决小国家监管体系强化面临的挑战。
BMJ Glob Health. 2020 Mar 2;5(2):e001912. doi: 10.1136/bmjgh-2019-001912. eCollection 2020.
7
Cancer control in small island nations: from local challenges to global action.小岛国的癌症控制:从地方挑战到全球行动。
Lancet Oncol. 2019 Sep;20(9):e535-e548. doi: 10.1016/S1470-2045(19)30511-X. Epub 2019 Aug 5.
8
Falsified and Substandard Drugs: Stopping the Pandemic.假药和劣药:遏制大流行。
Am J Trop Med Hyg. 2019 May;100(5):1058-1065. doi: 10.4269/ajtmh.18-0981.
9
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment.美国食品药品监督管理局对抗逆转录病毒药物的注册对全球获得艾滋病治疗的影响。
BMJ Glob Health. 2018 May 17;3(3):e000651. doi: 10.1136/bmjgh-2017-000651. eCollection 2018.